ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 187,65
0,69%
Dow Jones
39 387,76
0,85%
DAX
18 686,60
1,07%
Brent Oil
84,02
0,08%
Bitcoin
62 859,99
-0,30%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Astellas Pharma Inc (PK) (ALPMY)

  7. Astellas Pharma Inc (PK) (ALPMY) Actualités

ALPMY

Astellas Pharma (PK) (ALPMY)

Astellas Pharma Inc (PK)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:ALPMY
DateHeureSourceTitreSymboleSociété
15/12/202323h53Dow Jones NewsMerck, Pfizer, Astellas Get FDA OK For Expanded Use Of Keytruda Plus PadcevUSOTC:ALPMYAstellas Pharma Inc (PK)
01/12/202300h04Dow Jones NewsAstellas, Seagen: Cancer Treatment Padcev Supplemental Biologics License Application Gets FDA Priority ReviewUSOTC:ALPMYAstellas Pharma Inc (PK)
22/09/202313h02Dow Jones NewsMerck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits EndpointsUSOTC:ALPMYAstellas Pharma Inc (PK)
07/08/202316h41Dow Jones NewsPoseida Therapeutics Shares Leap on Astellas InvestmentsUSOTC:ALPMYAstellas Pharma Inc (PK)
07/08/202315h58Dow Jones NewsPoseida Therapeutics in $50 Million Investment Deal With AstellasUSOTC:ALPMYAstellas Pharma Inc (PK)
01/05/202302h57Dow Jones NewsAstellas Pharma to Buy Iveric Bio for About $5.9 BillionUSOTC:ALPMYAstellas Pharma Inc (PK)
09/01/202316h49Dow Jones NewsSelecta Biosciences Shares Rise 11% After Licensing Deal With Astellas PharmaUSOTC:ALPMYAstellas Pharma Inc (PK)
25/10/202212h26Dow Jones NewsTaysha Gene Therapies Shares Soar Premarket on Astellas InvestmentUSOTC:ALPMYAstellas Pharma Inc (PK)
28/06/202216h28Dow Jones NewsSutro Biopharma Shares Rise 24% After Collaboration With Astellas PharmaUSOTC:ALPMYAstellas Pharma Inc (PK)
28/06/202202h37Dow Jones NewsSutro Biopharma Shares Soar 67% on Cancer Treatment Collaboration with AstellasUSOTC:ALPMYAstellas Pharma Inc (PK)
13/04/202218h31Dow Jones NewsEuropean Commission Approves Drug for Urothelial CancerUSOTC:ALPMYAstellas Pharma Inc (PK)
17/12/202113h37Dow Jones NewsAstellas Pharma, Seagen Get CHMP Positive Opinion for PadcevUSOTC:ALPMYAstellas Pharma Inc (PK)
11/08/202113h54Dow Jones NewsFDA Rejects FibroGen's Roxadustat for Anemia of Chronic Kidney DiseaseUSOTC:ALPMYAstellas Pharma Inc (PK)
21/12/201722h17Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)USOTC:ALPMYAstellas Pharma Inc (PK)
29/09/201719h03Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)USOTC:ALPMYAstellas Pharma Inc (PK)
22/08/201614h50Dow Jones NewsPfizer Adds Key Cancer Drug in $14 Billion Biotech DealUSOTC:ALPMYAstellas Pharma Inc (PK)
09/07/201609h02Dow Jones NewsCorrections & Amplifications -- WSJUSOTC:ALPMYAstellas Pharma Inc (PK)
07/07/201607h20Dow Jones NewsTest Aids Prostate Cancer TreatmentUSOTC:ALPMYAstellas Pharma Inc (PK)
02/06/201600h40Dow Jones NewsSanofi Asks for Record Date for Vote on Medivation's BoardUSOTC:ALPMYAstellas Pharma Inc (PK)
29/04/201600h10Dow Jones NewsDrugmakers Place Big Bets on Cancer MedicinesUSOTC:ALPMYAstellas Pharma Inc (PK)
29/03/201616h50Dow Jones NewsLawmakers Target Medivation Over Drug PricesUSOTC:ALPMYAstellas Pharma Inc (PK)
04/12/201522h03The Motley FoolOcata Therapeutics Almost Doubled in November -- Here's WhyUSOTC:ALPMYAstellas Pharma Inc (PK)
25/11/201515h04The Motley FoolJohnson & Johnson's Latest FDA Approval Could Spell Problems for AmgenUSOTC:ALPMYAstellas Pharma Inc (PK)
23/11/201516h07The Motley Fool3 Value Stocks Near 52-Week Lows Worth BuyingUSOTC:ALPMYAstellas Pharma Inc (PK)
06/11/201518h40The Motley FoolMedivation Inc is Down Today -- But Why?USOTC:ALPMYAstellas Pharma Inc (PK)
02/11/201513h34The Motley Fool3 Stocks to Buy Now in BiotechUSOTC:ALPMYAstellas Pharma Inc (PK)
15/07/201520h33Dow Jones NewsAsian Shares: China Stocks Tumble as Investors Doubt Beijing's HelpUSOTC:ALPMYAstellas Pharma Inc. ADR
22/03/201512h01The Motley FoolBest One-Drug Wonder Stock for 2015USOTC:ALPMYAstellas Pharma Inc (PK)
30/01/201505h30Dow Jones NewsValeant to Buy Prostate-Cancer Drug From DendreonUSOTC:ALPMYAstellas Pharma Inc. ADS
30/01/201505h10Dow Jones NewsValeant in Deal to Buy Prostate-Cancer Drug Provenge From DendreonUSOTC:ALPMYAstellas Pharma Inc. ADS
 Showing the most relevant articles for your search:USOTC:ALPMY

Dernières Valeurs Consultées

EU
BNP
BNP Paribas
NYSE
DIS
Walt Disney
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
KO
Coca Cola
EU
VIV
Vivendi
SPI
SP500
S&P 500
EU
BN
Danone
COIN
BTCUSD
Bitcoin
EU
BEL20
Bel 20
NASDAQ
GOOGL
Alphabet
FTSE
UKX
FTSE 100
NASDAQ
AAPL
Apple
EU
CS
Axa
NYSE
NKE
Nike
EU
HO
Thales
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés